Miniatura

Fitxers

700255.pdf (2.4 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2021-01-01

Llicència de publicació

cc by (c) Caballero-Camino et al
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/174504

Synthetic conjugates of ursodeoxycholic acid inhibit cystogenesis in experimental models of polycystic liver disease

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1002/hep.31216

Resum

Background and aims: polycystic liver diseases (PLDs) are genetic disorders characterized by progressive development of symptomatic biliary cysts. Current surgical and pharmacological approaches are ineffective, and liver transplantation represents the only curative option. Ursodeoxycholic acid (UDCA) and histone deacetylase 6 inhibitors (HDAC6is) have arisen as promising therapeutic strategies, but with partial benefits. Approach and results: here, we tested an approach based on the design, synthesis, and validation of a family of UDCA synthetic conjugates with selective HDAC6i capacity (UDCA-HDAC6i). Four UDCA-HDAC6i conjugates presented selective HDAC6i activity, UDCA-HDAC6i #1 being the most promising candidate. UDCA orientation within the UDCA-HDAC6i structure was determinant for HDAC6i activity and selectivity. Treatment of polycystic rats with UDCA-HDAC6i #1 reduced their hepatomegaly and cystogenesis, increased UDCA concentration, and inhibited HDAC6 activity in liver. In cystic cholangiocytes UDCA-HDAC6i #1 restored primary cilium length and exhibited potent antiproliferative activity. UDCA-HDAC6i #1 was actively transported into cells through BA and organic cation transporters. Conclusions: these UDCA-HDAC6i conjugates open a therapeutic avenue for PLDs.

Matèries

Àcids, Mètodes experimentals, Malalties del fetge

Matèries (anglès)

Acids, Experimental methods, Liver diseases

Citació

Col·leccions

Articles publicats en revistes (Ciències Fisiològiques)

Citació

CABALLERO-CAMINO, Francisco j., RIVILLA, Iván, HERRAEZ, Elisa, BRIZ, Oscar, SANTOS-LASO, Álvaro, IZQUIERDO-SANCHEZ, Laura, LEE-LAW, Pui y., RODRIGUES, Pedro m., MUÑOZ-GARRIDO, Patricia, JIN, Sujeong, PEIXOTO, Estanislao, RICHARD, Seth, GRADILONE, Sergio a., PERUGORRIA, Maria j., ESTELLER, Manel, BUJANDA, Luis, MARÍN, José j. g., BANALES, Jesús m., COSSIO, Fernando p.. Synthetic conjugates of ursodeoxycholic acid inhibit cystogenesis in experimental models of polycystic liver disease. _Hepatology_. 2020. Vol. 73, núm. 1, pàgs. 186-203. [consulta: 20 de gener de 2026]. ISSN: 0270-9139. [Disponible a: https://hdl.handle.net/2445/174504]

Exportar metadades

JSON - METS

Compartir registre